SERVICES
Our business model is comprised of research & development, education, developing systems, formulation of products, and licensing of systems and product to our group of operating companies, commercial partners and third party manufacturers.
RESEARCH & DEVELOPMENT
EDUCATION
DEVELOPING SYSTEMS
MANUFACTURING
LICENSING OF SYSTEMS & FORMULAS
DESIGN & FORMULATION OF PRODUCTS
OUR DIFFERENTIATORS
.
After 50 years of identifying how to repair, regenerate and or maintain a cellular organisms we have become stewards of their optimal conservation. This entails coupling genome sequencing, big data and nutrition into an effective delivery system we call ADVANCED HYDROLIZATION that ultimately achieves BIO-CELLULAR OPTIMIZATION or a series of very effective anti-aging systems.
INTELLECTUAL PROPERTIES
A comprehensive library of protocols, curriculums, and formulas that validate the effectiveness and success of our disruptive MULTIDIMENSIONAL HEALTH SUPPORT SYSTEM.
SUPERIOR SOLUTIONS
We design and formulate BIO-CELLULAR NUTRITION from cellular genetic specifications (i.e. what free-aminos acids are needed for a specific cellular structure) comprised of high quality nutrients and their optimal absorption.
PIONEERS IN BIO-CELLULAR NUTRITION
At the nucleus of our methodology we carefully match and formulate proteins with their amino acids to a cell’s specific genetic marker and metabolic absorption requirements.
USE CASES
Our vast acumen of use cases and applications cover five main verticals: Cellular Therapies, Nutraceuticals, Vitamin & Dietary Supplements, Skincare & Haircare.
OUR MISSION
As a disruptor and responsible industry leader we strive to share knowledge via qualitative information payloads in order to build intrinsic value and ensure the evolution of the human species.
Our institutional fortitude endeavors on building long lasting collaborative relationships with relevant academic bodies, associations and human initiatives.
The unified goal is to heighten our industry’s best practices, state of technological innovation, and elevate health standards by conducting broader in-depth research, case studies and benchmarking.
OUR VISION
We envision ourselves as a key contributor and facilitator in a more sustainable future. One with zero environmental impacts, zero impoverishment, and zero disease. A future where optimal cellular conservation extends life and becomes everyone’s legacy.
1969 – 1984 Bueno Aries, Argentina. The research and development to identify what sustains a cell, its building blocks and how they are delivered to ensure cell revitalization and longevity. The ground work amassed a library of empirical data and hundreds of formulas that shape our present day methodology and system of cellular therapies.
1985 – 1999 Bueno Aries, Argentina. Multifaceted collaboration focused on the study of biological and cellular therapies to share and facilitate empirical data with hundreds of doctors on the science of Biological Revitalization and Cellular Therapy. The collaboration included experts across functional medicine, endocrinology, neurology, exercise science, molecular biology, and nutritional biochemistry to help shape the system we know coin BIO-CELLULAR OPTIMIZATION.
1986 – 1995 Bueno Aries, Argentina. This collaboration extended its frameworks into clinical practice, medical training, and a symposium via the National Congress of Cotyledon and Placental Mesenchymal Tissue for dermal and hair revitalization. This included the design, formulation, and benchmarking of cellular therapies to aid in organ diseases and obesity.
1984 – 2003 Bueno Aries, Argentina. The Human Genome Project (HGP) was completed. HGP was an international scientific research project with the goal of determining the sequence of chemical base pairs which make up human DNA, and of identifying and mapping all of the genes of the human genome from both a physical and functional standpoint. It remains the world’s largest collaborative biological project. The project was proposed and funded by the US government; planning started in 1984, got underway in 1990, and was declared complete in 2003. We were able to verify and confirm our forty (40) years of research on cellular composition and building blocks was accurate and effective as the foundation for our systems; BIO-CELLULAR OPTIMIZATION, BIO-CELLULAR NUTRITION, ADVANCED HYDROLIZATION, MULTIDIMENSIONAL HEALTH SUPPORT SYSTEM.
2003-2015 Bueno Aries, Argentina. Our library of protocols and formulas grows to 450.
2012 – 2019 Bueno Aries, Argentina. Commercialization of our cellular therapies via global licensing in the North America, South America, Europe & GCC Region.
June 2019 Bueno Aries, Argentina. Miami, Florida. INSTBCO DBA BIOFARV INTERNATIONAL established in the USA.
2017-2022 Bueno Aries, Argentina. Miami, Florida. Successful research, formulation, testing and benchmarking of our cellular therapies into nutraceuticals and dietary supplements.
Jan 2022 Palm Beach, Florida. XHUM [x factor // human // unified // management] protocol and product line presented and launched.
Jan 2023 INSTBCO’s library of intellectual properties transferred, established and held Delaware.
Feb 2023 Signed forward agreements to with expert physicians in functional medicine, anti-aging, erectile dysfunction, hormone replacement, skincare, haircare and cellular therapies to license the use of protocols and resell products.
March 2023 INSTBCO association curriculum drafted.
Our robust library of protocols, formulas, and R&D infrastructure enables a broad range of applications general or bespoke to genetic centric requirements.
DELIVERING INNOVATION
Sustainability Goals
We are focused on building a long-term, sustainable business.